Bybit and Digital Artist Per Kristian Stoveland Sell Out Exclusive Collection, Open Edition Sales Ongoing
DUBAI, UNITED ARAB EMIRATES - Media OutReach - 22 September 2023 - Bybit, the world's…
3 years ago
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial
– Trial results to be submitted for presentation at upcoming medical meeting – BOTHELL, Wash.…
3 years ago
Mitsubishi Electric Announces Dividend Policy for the First Half of Fiscal 2024
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO:6503) announced today its dividend forecast for the first half (ending…
3 years ago
CLF Innovative Mold Height Setting and Clamping System: A Breakthrough in Two Platen Injection Molding Machine
Chuan Lih Fa (CLF) Machinery Works Co. Ltd, a globally renowned manufacturer of large plastic…
3 years ago
Kerry Logistics Network Won Two ESG Achievement Awards for the Second Consecutive Year
HONG KONG SAR - Media OutReach - 22 September 2023 - Kerry Logistics Network Limited…
3 years ago
China Eastern Airlines Join 2023 North Bund International Aviation Forum
SHANGHAI--(BUSINESS WIRE)--The 2023 North Bund International Aviation Forum was held in Shanghai on Sept. 22.…
3 years ago
CDFI joins forces with UnionPay International to launch dual shopping privileges to revitalize retailing in Hong Kong and Macau
Enjoy instant discounts and earn bonus member points at CDFI stores with UnionPay card HONG…
3 years ago
ECO Clean Office and Helpling Join Hands to Revolutionise Home Services
ECO Clean Office, a leading provider of cleaning services, has forged a partnership with Helpling,…
3 years ago
JTI: Combatting Illegal Trade and a Collective Approach to Sustainability Were the Focus at the Global Tobacco and Nicotine Forum in Seoul
SEOUL--(BUSINESS WIRE)--The Global Tobacco and Nicotine Forum (GTNF) took place in Seoul, South Korea 19-21…
3 years ago
Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial
First phase 3 results in breast cancer for Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan Plans…
3 years ago